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A heparin-bInding mitogen rat for rat hepatocytes was partially purified from hovme spleen by a combination of heparln-affinity, catIon-exchange 
and gel-filtration chromatography Besides stimulating rat hepatocytes, thts factor, whtch was designated spleen-dertved growth factor-3 (SDGF-3). 
exhibited mitogenic activtty for mouse eptdermai keratinocytes but not mouse fibroblasts. Its apparent epithehal specifcity and heparin-binding 
properties corresponded to those of keratinocyte growth factor (KGF). These findings, together wtth the fact that the mitogenic activity of SDGF-3 
was abohshed by a neutralizing monoclonal anttbody specific for KGF, identify this bovme spleen-derived hepatocyte mitogen as KGF. 
SDGF-3; Keratinocyte growth factor, Bovine spleen; Prrmary cultured hepatocyte, Heparin binding 
1. INTRODUCTION 
Control of growth in regenerating Iiver is one of the 
most attractive models for studying the mechanism of 
organ formation and repair [1,2]. Based on work with 
primary cultures of hepatocytes, EGF [3], TGF-cr [4], 
FGF-1 [5,6]; T. Tanahashi et al., submitted) and HGF/ 
SF [7-91 have been identified as growth factors for 
hepatocytes. In the course of exploring novel hepato- 
cyte mitogens, we demonstrated that bovine spleen con- 
tained at least three heparin-binding proteins that stim- 
ulated hepatocyte proliferation, two of which were 
FGF-1 and FGF-2 and the third was a novel growth 
factor that (1) eluted from a heparin-Sepharose column 
at 0.75 M NaCl, (2) dit not react with anti-FGF-2 anti- 
bodies, and (3) had mitogenic activity which was addi- 
tive with that of HGF [IO,1 11. We identify these growth 
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Abbrerratrons. KGF, keratinocyte growth factor (also destgnated 
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growth factor; TGF-a, transforming growth factor-a; FGF-1, fibro- 
blast growth factor-l (acidic FGF); FGF-2, fibroblast growth factor-2 
(basic FGF); HGFISF, hepatocyte growth factor/scatter factor; 
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ate; SDS-PAGE, sodium dodecyl sulfate-polyacrylamtde gel electro- 
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factors as KGF, a member of the FGF family (FGF-7) 
with epithelial target-cell specificity. 
2. MATERIALS AND METHODS 
Recombmant human KGF &as expressed in Escher&~ cob and 
purified as described elsewhere [12]. Mouse monoclonal antibody (des- 
ignated 164) was obtained using recombinant KGF as antigen. It 
specifically neutrahzes the mitogenic acttvity of KGF (J. Rubm, un- 
pubhshed observations) 
2.2. Cell Culture 
Isolation and primary culture of rat hepatocytes were performed as 
previously described [1 11. BALB/MK epidermal keratinocytes [13] 
were cultured m minimal essential medium (MEM) supplemented with 
5 ngiml of EGF (Collaboratlv~ Research Inc.) and 10% fetal bovine 
serum (FBS, Gibco BRL). BALBI3T3 cells were cultured m MEM 
supplemented with 10% FBS. 
2.3. Assay oj‘ DNA synthesis 
DNA synthesis of hepatocytes was determmed as described previ- 
ously [l 11. DNA synthesis of BALBlMK cells was assayed with cul- 
tures that had been seeded at a density of 2 x lo5 cells/O.4 ml/well m 
48-well plates (Sumltomo Bakelite Inc.. Tokyo) precoated with ti- 
bronectin (Collaborattve Research Inc.). At confluence, the medmm 
was changed to serum-free MEM supplemented wtth 30 nM NaSeO, 
and 5 /g/ml transferrm. EGF or test samples were added to the culture 
2 days after the switch to serum-free medium. Incorporatton of 
[‘Hjthymtdine (ICN. 74 kBqlm1. 2.1 TBq/mmol) was momtored for 6 
h begmnmg 17 h after addition of samples. The cells were washed with 
Ca”, Mg”-free phosphate-buffered saline (PBS(-)) once and with 5% 
trichloroacetic acid twtce. They were solubilized wtth 0.25 M NaOH 
and the radioactivtty was counted with a hwuid scintillation counter 
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(Beckman). DNA syntheses of BALB/3T3 cells was determmed as 
described for BALB/MK cells except that cells were seeded m a fi- 
bronectm-coated 96-well microttter plate (Sumitomo Bakehte Inc., 
Tokyo) at a density of 10’ cells/O 2 ml/well 
All procedures mere performed at 4’C or on tee. Preparatton of a 
soluble matrix fractton from bovme spleen was performed as described 
previously [11] After thts step. all buffers contatned 0.01% CHAPS 
to avotd the non-specific absorption to resm or tubes. The soluble 
matrtx fractton was applied on a heparu-Sepharose column (5 x 15 
cm) (Pharmacta) that had been equtlibrated with PBS(-). After wash- 
ing vvtth PBS(-), bound proteins were eluted wtth a linear gradtent of 
NaCl m PBS( -) Hepatocyte mttogemc activity was resolved mto three 
peaks by this step: Peak I, Peak 2, and Peak 3 eluted at 1.8 M NaCl 
(PBS-l.65 M NaCl). 1.35M NaCl (PBS-l.2 M NaCl). and 0 75M 
NaCl (PBS-O.6 M NaCI), respecttvely [l 11. Peak 3 was dralyzed 
agamst PBS(-) and applied on an S-Sepharose column (1x10 cm) 
(Pharmacta) equthbrated with PBS(-). After washmg the column, 
acttvtty was eluted wtth a linear gradtent of NaCl m PBS(-). Fracttons 
of 2 4 ml were collected. Most of the activity was elutcd at 0 X5 M 
NaCl (PBS-O.7 M NaCI). This major peak was then loaded on a 
Superdex 75 gel filtration column (2.6 x 60 cm) (Pharmacta), equth- 
brated wtth 0 15 M NaCl in PBS(-), and eluted with the same bul‘rer 
Fractions of 5ml were collected Acttve fracttons were pooled and 
concentrated by ultrafiltratton (Centrtcon-3. molecular mass. 3.000 
Da cutoff. Amtcon). 
3. RESULTS 
3.1. Partial pur$cation oJ’SDGF-3 
Hepatocyte growth-promoting activity in the soluble 
matrix fraction from bovine spleen was separated into 
three fractions by heparin-Sepharose column chroma- 
tography [1 11. Among them, Peak 1 and Peak 2 were 
identified as FGF-2 and FGF-1 or closely related mole- 
cules, respectively [ll]. Peak 3. an unidentified spleen- 
derived growth factor for hepatocytes, eluted at 0.75 M 
NaCl. Its activity was further purified by sequential 
column chromatography using S-Sepharose and Super- 
dex 75. Most of the activity was recovered from the 
S-Sepharose resin at 0.85 M NaCl, while a minor peak 
eluted at 0.5 M NaCl (Fig. 1). The major peak was then 
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Fig. 1 S-Sepharose column chromatography of a hepatocyte mttogen. 
Chromatography was performed as described in section 2 Open ctr- 
cles: DNA syntheses. Values are means f SE. (number of wells = 3). 
The horizontal bars mdtcate the pooled fracttons. 
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Fig. 2 Superdex 75 gel filtration chromatography of the active frac- 
tion of the S-Sepharose column chromatography Chromatography 
Has performed as described m sectton 2. Open circles: DNA synthesis 
Values are means + S E. (number of wells = 3). The elution position 
of molecular mass markers were mdrcated by the arrows with mass 
numbers The hortzontal bars mdtcate the pooled fracttons 
applied onto a Superdex 75 gel filtration column. Hepa- 
tocyte mitogenic activity was separated from most of 
the protein and eluted at a position corresponding to 17 
kDa (Fig. 2). When the active fractions were analyzed 
by SDS-PAGE. mutliple bands were detected. How- 
ever, only a 17-kDa silver-stained band corresponded 
in intensity to the observed activity (data not shown). 
This active peak containing SDGF-3 was concentrated 
by ultrafiltration for further analysis. 
3.2. Turget cell spec$cit~~ of SDGF-3 
The conditions for elution of SDGF-3 from heparin- 
Sepharose suggested its possible relationship to ker- 
atinocyte growth factor (KGF), a member of the FGF 
family (FGF-7) with epithelial target-cell specificity 
[14.15]. To determine whether SDGF-3 had a similar 
epithelial specificity. we examined its growth promotmg 
activity on BALB/MK cells (mouse epithelial cell line) 
and BALB/3T3 cells (a mouse fibroblast line). EGF, a 
known mitogen for both BALB/MK and BALB/3T3 
cells. was used as a positive control. As shown in Fig. 
3A,B, SDGF-3 stimulates DNA synthesis of BALB/ 
MK cells more potently than EGF. However, it did not 
stimulate DNA synthesis of BALB/3T3 cells (Fig. 
3C,D). 
3.3. Effects of SDGF-3 or reconlbimmt KGF on DNA 
synthesis of heputocytes in the presence or absence 
of anti-KGF neutralizing antihod? 
Because the heparin elution and target-cell properties 
of SDGF-3 matched those of KGE we tested the ability 
of recombinant KGF to stimulate DNA synthesis in rat 
hepatocytes. an epithelial cell type on which its activity 
had not been analyzed. As shown in Fig. 4A, KGF 
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Ftg 3 Target cells specificity of SDGF-3. Acttvtttes of SDGF-3 or 
EGF for the growth of BALB/MK cells and BALB/3T3 cells were 
assayed as descrtbed in section 2. Closed circles, SDGF-3 (A.C): open 
ctrcles, EGF (B.D): solid hne. BALBiMK cells (A.B); broken lme; 
BALB/3T3 cells (C,D). Concentrattons of SDGF-3 were expressed as 
percent of medtum volume. Values are means * SE. (number of 
wells = 2). 
stimulated DNA synthesis in rat hepatocytes and the 
activity was abolished by an anti-KGF monoclonal an- 
tibody specific for KGF. When the same KGF-neutral- 
izing antibody was tested against SDGF-3 in the rat 
hepatocyte bioassay, a similar pattern of inhibition was 
observed (Fig. 4B). 
4. DISCUSSION 
We previously reported that the bovine spleen con- 
tained at least three heparin-binding hepatocyte growth 
factors. Two major factors were FGF-1 and FGF-2 or 
closely related molecules. The present study demon- 
strates that the third factor, SDGF-3, is KGF based on 
their indistinguishable heparin elution profiles. target- 
cell specificity and immuno-crossreactivity with a spe- 
cific KGF-neutralizing monoclonal antibody. 
KGF was first isolated from conditioned medium of 
a human embryonic lung fibroblast cell line as a hepa- 
rin-binding growth factor for BALB/MK cells. It does 
not stimulate the growth of fibroblasts or endothelial 
cells suggesting that mitogenic activity of KGF is spe- 
cific for epithelial cells [14]. An analysis of cloned 
cDNA revealed that kGF is a 194 amino acid polypep- 
tide with calculated mass of 22,512 Da and structurally 
related to the fibroblast growth factors [15]. Purified 
native KGF lacked the amino-terminal 31 amino acids, 
which included a putative signal peptide sequence. The 
calculated mass of native KGF, 18,328 Da differs from 
the observed by SDS-PAGE (2628 kDa), presumably 
due to N-linked glycosylation at the putative site of 
Asp,,-Cys-Ser [15]. In the present study, the mass of 
SDGF-3 was judged to be about 17 kDa by both gel 
filtration and SDS-PAGE. The difference in size be- 
tween SDGF-3 and the previously characterized native 
human KGF may be due to the absence of glycosylation 
and/or N-terminal truncation is SDGF-3. A mitogeni- 
tally active, N-terminally truncated - kDa KGF mole- 
cule also has been isolated from embryonic lung fibro- 
blast conditioned medium (J. Rubin, unpublished ob- 
servations). Similarly, recombinant expression of N-ter- 
minally truncated KGF molecules produced in Escher- 
ichiu co/i retained mitogenic activity for BALB/MK 
cells [12]. For the definitive explanation of this differ- 
ence in molecular mass, amino acid sequence analysis 
of SDGF-3 will be required. 
The ability of KGF to stimulate DNA synthesis in rat 
hepatocytes broadens the array of epithelial targets for 
this growth factor. Other epithelial cells responsive to 
KGF include: keratinocytes, mammary and bronchial 
epithelial cells [14]; type II pneumocytes [16]: prostatic 
epithelial cells ([17] and manuscript in preparation). 
There also is indirect evidence that this growth factor 
stimulates the proliferation and/or differentiation of 
other epithelial cells in the male and female reproduc- 
tive tracts (manuscripts submitted or in preparation). In 
all of these contexts, the data is consistent with a para- 
crine mode of action. By contrast, a recent study indi- 
cated undetectable levels of KGF transcripts in normal 
liver or after partial hepateclomy [ 181. Thus, our present 
demonstration of KGF mitogenic activity for hepato- 
cytes and the recovery of KGF form bovine spleen raise 
the possibility that KGF might have an endocrine mode 
of action, reaching the liver via the portal circulation. 
In this regard, it might resemble HGF/SF. another 
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Fig. 4. Effects of SDGF-3 or recombmant KGF on DNA synthesis 
of hepatocytes m the presence or absence of anti-KGF neutralizmg 
antibody. Each amount of SDGF-3 or recombmant KGF were incu- 
bated wtth or without 2.5 pg of anti-KGF monoclonal antibody (des- 
ignated as lG4) m a total volume of 12.5 ~1 wtth PBS(-) contaming 
10 mg/ml BSA at room temperature for 2 h. Then, they were added 
to cultures. Open circles, recombinant KGF (A): closed ctrcles. 
SDGF-3 (B); sold line, with antt-KGF antibody; broken lme. without 
antibody. Values are means f S.E. (number of wells = 3). 
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mesenchymally-derived hepatocyte mitogen which is 
thought to function as a paracrine factor in some set- 
tings, including liver regeneration (for reviews see 
[I .19]). However, HGF/SD also appears to be recruited 
from distant sites such as the spleen and lung following 
liver injury [20]. Therefore, it will be of interest to deter- 
mine whether KGF expression increases in spleen after 
liver injury and whether its secretion into the blood- 
stream rises accordingly. 
S-Sepharose column chromatography revealed a 
minor hepatocyte mitogenic activity in addition to 
SDGF-3 (KGF) (Fig. 1). This minor activity was eluted 
at 0.75 M NaCl from a heparin-Sepharose column, and 
at 0.35 M from an S-Sepharose column. Thus, there 
remains a possibility that this activity may reflect a 
novel heparin-binding hepatocyte growth factor. 
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